# A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

> **NCT01920737** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 39 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Daunorubicin
- **DRUG:** Vincristine
- **DRUG:** Prednisone
- **DRUG:** PEG-Asparaginase
- **DRUG:** Methotrexate
- **DRUG:** 6-MP (6-Mercaptopurine)
- **DRUG:** Cyclophosphamide
- **DRUG:** Cytarabine
- **DRUG:** Leucovorin
- **DRUG:** Dexamethasone
- **OTHER:** Blood draw
- **DEVICE:** CT/PET scans

## Key facts

- **NCT ID:** NCT01920737
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-08-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920737, "A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01920737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*